Mochi Health Reduced Compounded Medication Prices
The company adjusted its pricing structure for weight loss medications and launched a new integrated lab testing service.
Updated on Sept. 29, 2026 in Weight Loss
Live Poll
Do you feel that access to weight-loss treatments is becoming more affordable for your household?
Mochi Health has updated its pricing for compounded GLP-1 medications, now tying costs to specific dosage levels. The provider also introduced an integrated lab-testing service for its members across most of the United States.
Why it matters
By linking medication costs to dosage levels, the company aims to provide more affordable options for patients beginning their treatment on lower introductory doses. This shift comes as patients continue to seek accessible alternatives for compounded GLP-1 weight loss treatments.
Compounded semaglutide now starts at $60 monthly, while compounded tirzepatide starts at $90. The company also offers core health panel lab testing starting at $26 for its members.
The players
Mochi Health
Mochi Health is a telehealth provider that specializes in weight loss management services and provides access to various GLP-1 medications.
The details
Patients can access these services through a 30-minute virtual appointment with a licensed provider, followed by requested bloodwork through the Mochi portal. While the medication program is available nationally, the new lab services are not currently offered in New York, New Jersey, Rhode Island, or Hawaii.
Timeline
September 29, 2026: Mochi Health announced its new pricing model and integrated lab-testing service.
Health Landscape
This development follows the regulatory framework established by the FDA's status of compounded GLP-1 products. The expansion of these services reflects a broader trend in telehealth platforms offering integrated care despite the non-FDA-approved nature of the medications.
Patients may now see lower monthly expenses if they are prescribed lower introductory doses of compounded GLP-1 medications. Users in New York, New Jersey, Rhode Island, and Hawaii should note they cannot currently utilize the new integrated lab-testing services.
The takeaway
Patients interested in telehealth weight loss services should compare membership costs, which currently start at $39 for the first month. Understanding that compounded medications differ from FDA-approved versions is essential when evaluating these treatment paths.
Further reading
For additional context on how providers are managing clinical care, visit the Weight Loss section.
Live Poll
Do you feel that access to weight-loss treatments is becoming more affordable for your household?
